For the quarter ending 2026-03-31, RMTI had -$1,102K decrease in cash & cash equivalents over the period. -$592K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -1,605 | -554 | -4,760 | - |
| Depreciation and amortization | 511 | 546 | 544 | 1,102 |
| Stock-based compensation | 479 | 457 | 532 | 827 |
| Write-off of inventory | 0 | 0 | 0 | 178 |
| Change in inventory reserves | - | -364 | -61 | - |
| Non-cash lease expense from right of use assets | 512 | 525 | 525 | 1,091 |
| Amortization of debt financing costs and accretion of debt discount and premium | 88 | 89 | 89 | 176 |
| Loss on disposal of assets | -178 | -1 | 1 | -57 |
| Realized gain on sale of investments | 120 | 86 | 181 | - |
| Gain on early termination of lease liability | - | 0 | 24 | - |
| Provision for credit losses | - | 246 | - | - |
| Accounts receivable | 682 | 61 | 244 | -207 |
| Inventory | -369 | -904 | -257 | -1,618 |
| Prepaid and other assets | -426 | 78 | 573 | -1,043 |
| Accounts payable | 1,446 | 474 | 23 | -1,367 |
| Lease liabilities | -306 | -433 | -421 | -808 |
| Accrued and other liabilities | -1,463 | 625 | -139 | -2,165 |
| Deferred license revenue | 0 | 0 | 0 | -475 |
| Changes in operating assets and liabilities | - | 1,613 | - | - |
| Net cash used in operating activities | -167 | 2,291 | -1,307 | -1,643 |
| Purchases of investments available-for-sale | 7,072 | 11,245 | 7,080 | 5,877 |
| Proceeds from sales of investments available-for-sale | 7,200 | 7,200 | 3,000 | 6,000 |
| Purchases of equipment | 425 | 86 | 229 | 227 |
| Proceeds from sale of equipment | 175 | - | - | - |
| Net cash used in investing activities | -122 | -4,131 | -4,309 | -104 |
| Payments on insurance financing note payable | 198 | 198 | 198 | 268 |
| Proceeds from issuance of common stock | - | 0 | 7,816 | 0 |
| Payments on finance lease liabilities | 115 | 111 | 124 | 294 |
| Deferred consideration paid in connection with evoqua asset acquisition | 500 | 750 | 750 | 871 |
| Net cash used in financing activities | -813 | -1,059 | 6,744 | -1,433 |
| Effect of exchange rate changes on cash and cash equivalents | - | 0 | 0 | 0 |
| Net decrease in cash and cash equivalents | -1,102 | -2,899 | 1,128 | -3,180 |
| Cash and cash equivalents at beginning of period | 10,711 | 13,610 | 15,662 | - |
| Cash and cash equivalents at end of period | 9,609 | 10,711 | 13,610 | - |
ROCKWELL MEDICAL, INC. (RMTI)
ROCKWELL MEDICAL, INC. (RMTI)